- Report
- February 2026
- 250 Pages
Global
From €4085EUR$4,490USD£3,489GBP
- Report
- July 2026
- 379 Pages
Global
From €5322EUR$5,850USD£4,546GBP
- Report
- July 2026
- 295 Pages
Global
From €5322EUR$5,850USD£4,546GBP
- Report
- May 2026
- 138 Pages
Global
From €2729EUR$2,999USD£2,330GBP
€3638EUR$3,999USD£3,107GBP
- Report
- April 2026
- 160 Pages
Global
From €3021EUR$3,320USD£2,580GBP
€3776EUR$4,150USD£3,225GBP
- Report
- April 2026
- 150 Pages
North America
From €2729EUR$2,999USD£2,330GBP
€3638EUR$3,999USD£3,107GBP
- Report
- January 2026
- 192 Pages
Global
From €3225EUR$3,545USD£2,755GBP
€3584EUR$3,939USD£3,061GBP
- Report
- July 2025
- 350 Pages
Global
From €4503EUR$4,949USD£3,846GBP
- Report
- August 2025
- 150 Pages
Global
From €2875EUR$3,160USD£2,455GBP
€3594EUR$3,950USD£3,069GBP
- Report
- July 2026
- 196 Pages
Global
From €3225EUR$3,545USD£2,755GBP
€3584EUR$3,939USD£3,061GBP
- Report
- June 2026
- 192 Pages
Global
From €3225EUR$3,545USD£2,755GBP
€3584EUR$3,939USD£3,061GBP
- Report
- June 2026
- 187 Pages
Global
From €3225EUR$3,545USD£2,755GBP
€3584EUR$3,939USD£3,061GBP
- Report
- January 2026
- 190 Pages
Global
From €3225EUR$3,545USD£2,755GBP
€3584EUR$3,939USD£3,061GBP
- Report
- January 2026
- 180 Pages
Global
From €3225EUR$3,545USD£2,755GBP
€3584EUR$3,939USD£3,061GBP
- Report
- January 2026
- 194 Pages
Global
From €3225EUR$3,545USD£2,755GBP
€3584EUR$3,939USD£3,061GBP
- Report
- January 2026
- 182 Pages
Global
From €3225EUR$3,545USD£2,755GBP
€3584EUR$3,939USD£3,061GBP
- Report
- January 2026
- 191 Pages
Global
From €3225EUR$3,545USD£2,755GBP
€3584EUR$3,939USD£3,061GBP
- Report
- January 2026
- 196 Pages
Global
From €3225EUR$3,545USD£2,755GBP
€3584EUR$3,939USD£3,061GBP
- Report
- January 2026
- 194 Pages
Global
From €3225EUR$3,545USD£2,755GBP
€3584EUR$3,939USD£3,061GBP
- Report
- August 2025
- 184 Pages
Global
From €3225EUR$3,545USD£2,755GBP
€3584EUR$3,939USD£3,061GBP

The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus.
The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more